Results 151 to 160 of about 86,105 (313)

Rilzabrutinib for the Treatment of Immune Thrombocytopenia

open access: yesEuropean Journal of Haematology, Volume 115, Issue 1, Page 4-15, July 2025.
ABSTRACT Advancements in the understanding of ITP pathogenesis have led to significant improvements in disease management through the use of both traditional immunosuppressive strategies and novel targeted therapies. However, a subset of patients remains refractory to treatment or achieves only transient benefits, underscoring the need for alternative ...
Caterina Labanca   +12 more
wiley   +1 more source

Mycobacterium tuberculosis - the 10 years of epidemiological and diagnostics studies [PDF]

open access: yes, 2005
Tuberculosis (ТВ) is the main bacterial pathogen that causes more deaths than AIDS, malaria and all infectious diseases. The unusual long doubling time (about 24h), highly hydrophobic cell envelope resistant to chemical lysis was the reason to delay ...
Boruń-Popławska, Marta   +3 more
core  

Hidradenitis Suppurativa Treatment During Pregnancy and Lactation: Navigating Challenges

open access: yesInternational Journal of Dermatology, Volume 64, Issue 7, Page 1173-1185, July 2025.
ABSTRACT Hidradenitis suppurativa (HS), or acne inversa, is a chronic inflammatory skin condition primarily affecting skin folds such as the axilla, groins, and the inframammary, perineal, and perianal regions. It is characterized by painful abscesses, sinus tracts, and scarring.
Laşin Özbek   +3 more
wiley   +1 more source

Short-Term Administration of Rifampin in the Prevention or Eradication of Infection Due to Foreign Bodies [PDF]

open access: yes, 2017
Short-term administration of rifampin was evaluated as a means of preventing or eradicating infection due to foreign bodies. Tissue cages were implanted into guinea pigs and subsequently infected with 103 colony-forming units of Staphylococcus aureus ...
Tshefu, K.   +2 more
core  

Rifampin in Experimental Endocarditis Due to Staphylococcus aureus in Rabbits [PDF]

open access: yes, 2017
Rifampin possesses unique activity against Staphylococcus aureus. It is the most active antistaphylococcal antibiotic currently available and has been shown to be particularly effective in eradicating S.
Sande, Merle A.   +2 more
core  

Home - About - Disclaimer - Privacy